Heterogeneous Susceptibility of Valve Endothelial Cells to Mesenchymal Transformation in Response to TNFα
- 632 Downloads
Lack of understanding of the early mechanisms of aortic valve stenosis and calcification hinders the development of diagnostic and therapeutic intervention strategies. Inflammation is a known component of early aortic valve disease and can induce mesenchymal transformation in a subset of aortic valve endothelial cells. Here we present a three-dimensional culture system that allows transforming and non-transforming cells to be independently isolated and analyzed. We have used the system to identify and characterize the dynamic invasion and phenotypic transition of two distinct subsets of endothelial cells: those that invade and transform under TNFα treatment, and those that resist mesenchymal transformation and remain endothelial. We determine that non-transformed cells maintain control levels of endothelial genes VE-cadherin and eNOS, while transformed cells lose these endothelial characteristics and upregulate α-smooth muscle actin. Both subsets of cells have an inflammatory phenotype marked by increased ICAM-1, but transformed cells have increased MMP-9, Notch1, TGF-β, and BMP-4, while non-transformed cells do not. Transformed cells also have distinct effects on alignment of collagen fibers as they invade the hydrogel system, which is not found in control endothelial or interstitial valve cells. Understanding the role of transforming and non-transforming endothelial cells in valve disease will provide an important pathological link between early inflammation and later stages of disease. Discovery of the molecular signature of transformation-resistant endothelial cells could inform development of treatment strategies that promote survival of the valve endothelium.
KeywordsAortic valve Calcification EMT Invasion Inflammation Membrane Valve interstitial cells
The authors would like to thank Shirks Meats of Dundee, NY for providing porcine aortic valves. This study was supported by the National Science Foundation Graduate Research Fellowship (EF), the Alfred P. Sloan Foundation (EF), NIH Grant HL110328, NSF CBET-0955172, and the LeDucq Foundation.
Conflict of interest
- 2.Ankeny, R. F., V. H. Thourani, D. Weiss, J. D. Vega, W. R. Taylor, R. M. Nerem, and H. Jo. Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves: association with low BMP antagonists and SMAD6. PLoS ONE 6:e20969, 2011.PubMedCentralPubMedCrossRefGoogle Scholar
- 3.Balachandran, K., P. Alford, J. Wylie-Sears, J. A. Goss, A. Grosberg, J. Bischoff, E. Aikawa, R. A. Levine, and K. K. Parker. Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve. Proc. Natl. Acad. Sci. U.S.A. 108:19943–19948, 2011.PubMedCentralPubMedCrossRefGoogle Scholar
- 8.Chang, A. C. Y., Y. Fu, V. C. Garside, K. Niessen, L. Chang, M. Fuller, A. Setiadi, J. Smrz, A. Kyle, A. Minchinton, M. Marra, P. A. Hoodless, and A. Karsan. Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Dev. Cell 21:288–300, 2011.PubMedCrossRefGoogle Scholar
- 10.Fondard, O., D. Detaint, B. Lung, C. Choqueux, H. Adle-Biassette, M. Jarraya, U. Hvass, J. P. Couetil, D. Henin, J. B. Michel, A. Vahanian, and M. P. Jacob. Extracellular matrix remodeling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur. Heart J. 26:1333–1341, 2005.PubMedCrossRefGoogle Scholar
- 16.Gould, R. A., and J. T. Butcher. Isolation of valvular endothelial cells. J. Vis. Exp. 46:1–5, 2010.Google Scholar
- 17.Guerraty, M. A., G. R. Grant, J. W. Karanian, O. A. Chiesa, W. F. Pritchard, and P. F. Davies. Hypercholesterolemia induces side-specific phenotypic changes and peroxisome proliferator-activated receptor-pathway activation in swine aortic valve endothelium. Arterioscler. Thromb. Vasc. Biol. 30:225–231, 2010.PubMedCentralPubMedCrossRefGoogle Scholar
- 19.Hollier, B. G., A. A. Tinnirello, S. J. Werden, K. W. Evans, J. H. Taube, T. R. Sarkar, N. Sphyris, M. Shariati, S. V. Kumar, V. L. Battula, J. I. Herschkowitz, R. Guerra, J. T. Chang, N. Miura, J. M. Rosen, and S. A. Mani. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res. 73:1981–1992, 2013.PubMedCrossRefGoogle Scholar
- 26.Paranya, G., S. Vineberg, E. Dvorin, S. Kaushal, S. J. Roth, E. Rabkin, F. J. Schoen, and J. Bischoff. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am. J. Pathol. 159:1335–1343, 2001.PubMedCrossRefGoogle Scholar
- 27.Richards, J., I. El-Hamamsy, S. Chen, Z. Sarang, P. Sarathchandra, M. H. Yacoub, A. H. Chester, and J. T. Butcher. Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am. J. Pathol. 182:1922–1931, 2013.PubMedCrossRefGoogle Scholar
- 29.Stewart, W. J., and B. A. Carabello. Aortic valve disease. In: Textbook of Cardiovascular Medicine, edited by E. J. Topol, R. M. Califf, E. N. Prystowsky, J. D. Thomas, and P. D. Thompson. Philadelphia, PA: Lippincott Williams & Wilkins, 2006, pp. 366–388.Google Scholar